Quotes

Back To Menu

Tata India Pharma & Healthcare Fund (G) Equity - Pharma
INVEST

Plan: OPEN | Option: Growth | Rajat Srivastava

18 Dec 25 | 12:00 AM

29.93 -0.06 (-0.20%)

  • Underperforms

    -2.49%

    Return (1Y)

    underperformed by -50.80%

  • More Volatile

    0.90%

    Standard Deviation (1Y)

    Higher than by 0.90%

  • Inconsistent

    /1

    Months

    Has underperformed

  • Value research rating

    Not Rated

Scheme Trivia

  • Tata India Pharma & Healthcare Fund (G) fund has been the 9th best in 5Y performance in the Equity - Pharma category

  • Tata India Pharma & Healthcare Fund (G) fund has been given the 8th best Risk adjusted performance for the past 5Y in the Equity - Pharma category

  • Tata India Pharma & Healthcare Fund (G) fund has been the 9th best in the 5Y SIP performance in the Equity - Pharma category

Critical Parameters

Everyone of us wants to create wealth by investing in top funds. Have a look at the key parameters that you need to check before deciding to invest in a mutual fund.

Returns

In last 1 year Tata India Pharma & Healthcare Fund (G), has underperformed its benchmark, by -50.80% (CAGR difference)

-2.49%

Underperforms

This is -ve Alpha

Performance Chart for Rs

Invested in

19 Dec 2024

Risk

In last 1 year , the volatility of Tata India Pharma & Healthcare Fund (G),is Higher than its benchmark, by 0.90%

0.90%

More Volatile

Risk Meter

Peer Comparison on Risk - Return

Consistency

For out of Last 1 Months, i.e 0% of the times It has beaten its benchmark,

Consistency Meter

Outperforming Stocks Vs. Underperforming Stocks

Based on the last 1year analysis, currently there are, 9 Stocks beating the benchmark 25 Stocks not beating the benchmark

View Stock Composition